Bile diversion underlies Roux-en-Y antitumor benefits

Authors

Elizabeth R. Zunica, Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, LA 70808, USA.
Vance L. Albaugh, LSU Health Sciences Center - New OrleansFollow

Document Type

Article

Publication Date

6-25-2025

Publication Title

Science translational medicine

Abstract

Bile diversion in preclinical Roux-en-Y gastric bypass confers its antitumor effects independently of weight loss (Lässle et al., this issue).

First Page

eadx3814

PubMed ID

40560999

Volume

17

Issue

804

Recommended Citation

Zunica, Elizabeth R. and Albaugh, Vance L., "Bile diversion underlies Roux-en-Y antitumor benefits" (2025). School of Medicine Faculty Publications. 3905.
https://digitalscholar.lsuhsc.edu/som_facpubs/3905
10.1126/scitranslmed.adx3814